ACPU
ORGO icon

Arrowgrass Capital Partners (US)’s Organogenesis Holdings ORGO Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,793,000
Closed -$17.8M – 386
2017
Q4 		$17.8M Buy
1,793,000
+293,000
+20% +$2.91M 0.17% 144
2017
Q3 		$15M Buy
+1,500,000
New +$14.9M 0.11% 223

Other funds holding ORGO

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s ORGO Position: Q1 2018 in Review

Arrowgrass Capital Partners (US) sold out of Organogenesis Holdings (ORGO) in Q1 2018, closing a stake of 1,793,000 shares — an estimated $17.8M sold.

Arrowgrass Capital Partners (US) first reported a position in ORGO in Q3 2017 and held it in 2 quarters. The position peaked at $17.8M in Q4 2017. 31 funds tracked by Wall St. Rank hold ORGO as of Q1 2018.

  • Arrowgrass Capital Partners (US) reported no remaining Organogenesis Holdings position as of Q1 2018 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 1,793,000 Organogenesis Holdings shares in Q1 2018, an estimated $17.8M.
  • Arrowgrass Capital Partners (US) first reported a position in Organogenesis Holdings in Q3 2017 and held it in 2 quarters.
  • Arrowgrass Capital Partners (US)'s Organogenesis Holdings position peaked at $17.8M in Q4 2017.
  • 31 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2018.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2018, filed 15 May 2018.